Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-cycloserine for Smoking Cessation
NCT01399866Phase 3Completed
- Sponsor
- Massachusetts General Hospital
- Start
- May 2011
- Primary completion
- Oct 2013
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of d-cycloserine in nicotine dependence, sponsored by Massachusetts General Hospital. Started May 2011; status: completed.
02
Drugs
d-cycloserine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT01399866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01399866.